Committee to take evidence from engineering biology industry
The House of Lords Science and Technology Committee will hold an evidence session with Dr Jim Ajioka, Chief Scientific Officer at Colorifix, Will Milligan, CEO of Extracellular, and Rosemary Sinclair Dokos, Senior Vice President at Oxford Nanopore Technologies; and with Mark Bustard, CEO of the Industrial Biotechnology Innovation Centre and Dr Martin Turner, Associate Director of Policy, Public Affairs and Investor Relations at the Bioindustry Association.
Meeting details
The session will focus on engineering biology developments within the commercial sector; the challenges faced by companies wanting to scale up within the UK; and which areas within engineering biology are the most promising in the UK.
Possible question areas include:
- How companies are hoping to innovate on existing processes or products using engineering biology.
- The major challenges companies face in scaling up to large-scale, industrial processes and which Government initiatives could help.
- The areas of engineering biology where the UK has the right ecosystem to scale up.
- How the Government should encourage larger companies to take up engineering biology processes or products, and whether this requires a broader industrial strategy.
- Whether regulators are sufficiently well-resourced, in terms of expertise and capacity, to regulate engineering biology.